ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,552 | -76.8% | 865,938 | +93.1% | 0.03% | -78.6% |
| Q1 2023 | $282,535 | +102267.8% | 448,469 | +5.6% | 0.14% | -20.8% |
| Q4 2022 | $276 | -100.0% | 424,819 | +1.5% | 0.18% | -70.0% |
| Q3 2022 | $720,000 | +73.9% | 418,569 | +25.1% | 0.61% | +62.0% |
| Q2 2022 | $414,000 | +242.1% | 334,656 | +80.5% | 0.38% | +700.0% |
| Q1 2022 | $121,000 | -9.0% | 185,456 | +51.4% | 0.05% | +20.5% |
| Q4 2021 | $133,000 | -29.3% | 122,456 | +18.6% | 0.04% | -40.9% |
| Q3 2021 | $188,000 | -27.1% | 103,239 | +5.5% | 0.07% | -42.1% |
| Q2 2021 | $258,000 | +16.7% | 97,889 | +11.5% | 0.11% | -20.3% |
| Q4 2020 | $221,000 | -45.3% | 87,764 | +9.0% | 0.14% | -10.1% |
| Q3 2020 | $404,000 | +36.0% | 80,542 | -11.1% | 0.16% | -58.3% |
| Q2 2020 | $297,000 | +32.0% | 90,585 | -1.2% | 0.38% | -12.6% |
| Q1 2020 | $225,000 | -52.3% | 91,685 | -8.4% | 0.44% | -3.3% |
| Q4 2019 | $472,000 | – | 100,145 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |